Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and Leukemia, Megakaryocytic

pyrazines has been researched along with Leukemia, Megakaryocytic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battolla, B; Canestraro, M; Capodanno, A; Casini, A; Collecchi, P; Fazzi, R; Galimberti, S; Mattii, L; Orciuolo, E; Pacini, S; Petrini, M; Piaggi, S; Simi, P; Trombi, L; Veroni, F1
Buda, G; Canestraro, M; Fazzi, R; Galimberti, S; Guerrini, F; Khan, R; Maffei, R; Marasca, R; Orciuolo, E; Petrini, M1
Bonnet, PA; Chevillard, C; Gannoun-Zaki, L; Mathieu, MN; Michel, A; Zurbonsen, K1
Bonnet, PA; Chevillard, C; Michel, A; Vittet, D; Zurbonsen, K1
Choy, M; Dias, S; Hattori, K; Heissig, B; Lane, WJ; Moore, MA; Rabbany, SY; Rafii, S; Wood, J1

Other Studies

5 other study(ies) available for pyrazines and Leukemia, Megakaryocytic

ArticleYear
PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells.
    Leukemia research, 2008, Volume: 32, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression; Genes, Wilms Tumor; Humans; Leukemia, Megakaryoblastic, Acute; NF-kappaB-Inducing Kinase; Primary Myelofibrosis; Protease Inhibitors; Protein Serine-Threonine Kinases; Pyrazines

2008
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines.
    Leukemia, 2008, Volume: 22, Issue:3

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Down-Regulation; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Genes, Wilms Tumor; Humans; Hydroxamic Acids; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Chronic; Megakaryocytes; Neoplasm Proteins; Pyrazines; Vorinostat; WT1 Proteins

2008
Apoptotic effects of imidazo[1,2-a]pyrazine derivatives in the human Dami cell line.
    European journal of pharmacology, 1997, Feb-12, Volume: 320, Issue:2-3

    Topics: Adenosine; Apoptosis; Cell Division; Cyclic AMP; DNA; DNA Damage; Humans; Imidazoles; Isoenzymes; Leukemia, Megakaryoblastic, Acute; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Receptors, Purinergic P1; Receptors, Purinergic P2; Tumor Cells, Cultured

1997
Modulation of the megakaryoblastic Dami cell line differentiation by phosphodiesterase inhibitors and imidazo[1,2-a]pyrazine derivatives.
    Pharmacology & toxicology, 1997, Volume: 80, Issue:6

    Topics: Cell Differentiation; Cell Line; Cyclic GMP; Flow Cytometry; Glycoproteins; Humans; In Vitro Techniques; Leukemia, Megakaryoblastic, Acute; Phosphodiesterase Inhibitors; Pyrazines

1997
Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases.
    Blood, 2000, Dec-15, Volume: 96, Issue:13

    Topics: Adult; Animals; Blood Platelets; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Chemotactic Factors; Chemotaxis; Culture Media, Serum-Free; Enzyme Induction; Extracellular Matrix Proteins; Humans; Hydroxamic Acids; Leukemia, Megakaryoblastic, Acute; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Megakaryocytes; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pyrazines; Receptors, CXCR4; Recombinant Fusion Proteins; Sulfonamides; Thrombin; Thrombopoietin; Tissue Inhibitor of Metalloproteinase-1; Transfection; Tumor Cells, Cultured

2000